Bright Minds Biosciences (DRUG) Interest & Investment Income (2024 - 2026)
Bright Minds Biosciences (DRUG) posted Interest & Investment Income of $2.0 million for Q1 2026, up 234.29% on a QoQ basis from $586766.6 in Q4 2025, and up 452.54% year-over-year from $354996.0 in Q1 2025.
Bright Minds Biosciences (DRUG) Interest & Investment Income (2024 - 2026) Analysis & Trends
Bright Minds Biosciences' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- Quarterly Interest & Investment Income rose 452.54% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (up 777.43% YoY) and the FY2025 annual result came in at $1.1 million, up 4898.39% from the prior year.
- Interest & Investment Income was $2.0 million for Q1 2026 at Bright Minds Biosciences, up from $586766.6 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q1 2026 and bottomed at $3091.0 in Q4 2024.
- A 3-year average of $456275.3 and a median of $349348.9 in 2025 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2025 — Interest & Investment Income surged 18882.84% — and 2026, when it jumped 452.54%.
- Bright Minds Biosciences' Interest & Investment Income stood at $3091.0 in 2024, then jumped by 18882.84% to $586766.6 in 2025, then soared by 234.29% to $2.0 million in 2026.
- Business Quant data shows DRUG's Interest & Investment Income at $2.0 million in Q1 2026, $586766.6 in Q4 2025, and $384780.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Bright Minds Biosciences | 683.37 Mn | 683.37 Mn | - | 1.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 586,766.61 |
| Sep 30, 2025 | 384,780.85 |
| Jun 30, 2025 | 343,701.87 |
| Mar 31, 2025 | 354,996.01 |
| Dec 31, 2024 | 3,091.04 |
| Sep 30, 2024 | 4,403.45 |
| Jun 30, 2024 | 10,957.60 |